- MNK has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $173.7 million.
- MNK has traded 34,449 shares today.
- MNK is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in MNK with the Ticky from Trade-Ideas. See the FREE profile for MNK NOW at Trade-Ideas More details on MNK: Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. Currently there are 8 analysts that rate Mallinckrodt a buy, no analysts rate it a sell, and 4 rate it a hold. The average volume for Mallinckrodt has been 1.8 million shares per day over the past 30 days. Mallinckrodt has a market cap of $10.7 billion and is part of the health care sector and drugs industry. Shares are up 74.6% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Mallinckrodt as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share.